J. Moan

This year's research prize from the University of Oslo goes to professor Johan Moan from the Department of Radiation Biology at the Institute for Cancer Research.
The prize amounts to NOK 250.000, and will be awarded during UiO's annual banquet on September 2nd.

P. Wilkens

A study performed by research fellow and chiropractor Philip Wilkens from the orthopaedic centre at the Division of Surgery and Clinical Neuroscience confirms that glucosamine has no relieving effect on backache. The findings attract international attention, and are published in the prestigious journal "Journal of American Medical Association" (JAMA) (journal impact factor 31,7). The article - entitled "Effect of Glucosamine on Pain-related Disability in Patients with Chronic Low Back Pain and Degenerative Lumbar Osteoarthritis: A Randomized Controlled Trial" - is published in the July 7th issue of JAMA.

HA Stenmark

At the 2010 FEBS Congress in Gothenburg, Harald Stenmark from the Centre for Cancer Biomedicine and the Institute for Cancer Research was awarded the Sir Hans Krebs Medal. This medal is awarded annually by the Federation of European Biochemical Societies for "outstanding achievements in Biochemistry and Molecular Biology or related sciences". Recent awardees include Nobel laureates Aaron Ciechanover (2006) and Tim Hunt (2008). After receiving the medal, Stenmark presented a plenary lecture entitled "How a lipid mediates tumour suppression".

K. Sandvig

The Sandvig group has recently published a review article in "Nanomedicine" (journal impact factor 5,98) about the in vivo use of nanoparticles. The main focus is on metal-based nanoparticles for in vivo imaging and requirements for bringing such particles from in vitro studies and imaging in animals into common clinical use. Much of the discussion is also relevant for other type of nanoparticles and for their therapeutic use.

Lingjærde, Russnes, Vollan and Børresen-Dale

An article entitled "Genomic architecture characterizes tumor progression paths and fate in breast cancer patients" is published in the June 30th issue of "Science Translational Medicine" - one of the three respected peer-reviews journals published by The American Association for the Advancement of Science (AAAS) (the others being Science and Science Signaling).
The study emphasizes the relationship between structural genomic alterations, molecular subtype and clinical behavior, and show that objective score of genomic complexity is an independent prognostic marker in breast cancer.
The AAAS press office believes this paper will attract considerable media attention.